PAMP
PFE icon

Polar Asset Management Partners’s Pfizer PFE Stock Holding History

Polar Asset Management Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$4.3M – 1455
2021
Q3 		$4.3M Buy
+100,000
New +$4.43M 0.04% 441
2016
Q1 		– Sell
-31,620
Closed -$968K – 273
2015
Q4 		$968K Sell
31,620
-15,810
-33% -$497K 0.05% 182
2015
Q3 		$1.41M Buy
47,430
+36,890
+350% +$1.18M 0.09% 158
2015
Q2 		$335K Buy
+10,540
New +$344K 0.01% 195

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Polar Asset Management Partners's PFE Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Pfizer (PFE) in Q3 2024, closing a stake of 54,500 shares — an estimated $1.52M sold.

Polar Asset Management Partners first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $77.3M in Q4 2017. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Polar Asset Management Partners reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 54,500 Pfizer shares in Q3 2024, an estimated $1.52M.
  • Polar Asset Management Partners first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
  • Polar Asset Management Partners's Pfizer position peaked at $77.3M in Q4 2017.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.